D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$826M |
| 2 |
Microsoft
MSFT
|
+$549M |
| 3 |
Pinduoduo
PDD
|
+$305M |
| 4 |
Intel
INTC
|
+$274M |
| 5 |
Apple
AAPL
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$382M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$298M |
| 3 |
TWTR
Twitter, Inc.
TWTR
|
+$267M |
| 4 |
Procter & Gamble
PG
|
+$260M |
| 5 |
Meta Platforms (Facebook)
META
|
+$244M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.32% |
| 2 | Healthcare | 8.96% |
| 3 | Financials | 7.81% |
| 4 | Consumer Discretionary | 7.49% |
| 5 | Industrials | 4.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RAD
2701
DELISTED
Rite Aid Corporation
RAD
| $2.23M | ﹤0.01% |
668,222
+357,073
| +115% | +$1.7M |
|
2702
Banc of California
BANC
$3.09B
| $2.23M | ﹤0.01% |
140,069
-16,802
| -11% | -$274K |
|
2703
Astronics
ATRO
$3.73B
| $2.23M | ﹤0.01% |
259,712
+2,632
| +1% | +$19.5K |
|
|
TCN
2704
DELISTED
Tricon Residential Inc.
TCN
| $2.23M | ﹤0.01% |
289,100
-38,800
| -12% | -$324K |
|
2705
Sutro Biopharma
STRO
$425M
| $2.23M | ﹤0.01% |
27,559
-3,942
| -13% | -$274K |
|
|
HERA
2706
DELISTED
FTAC Hera Acquisition Corp. Class A Ordinary Shares
HERA
| $2.23M | ﹤0.01% |
+220,000
| New | +$2.2M |
|
|
BSAQ
2707
DELISTED
Black Spade Acquisition Co
BSAQ
| $2.23M | ﹤0.01% |
222,630
+5,501
| +3% | +$54.6K |
|
2708
CALL
Penumbra
PEN
$12.8B
| $2.22M | ﹤0.01% |
+10,000
| New | +$1.96M |
|
2709
Expensify
EXFY
$186M
| $2.22M | ﹤0.01% |
251,886
+208,986
| +487% | +$2.34M |
|
2710
Wendy's
WEN
$1.46B
| $2.22M | ﹤0.01% |
98,234
+63,492
| +183% | +$1.36M |
|
2711
Thryv Holdings
THRY
$132M
| $2.22M | ﹤0.01% |
116,866
+20,510
| +21% | +$400K |
|
2712
CALL
Upbound Group
UPBD
$1.2B
| $2.22M | ﹤0.01% |
98,300
-50,000
| -34% | -$1.07M |
|
|
INVX
2713
Innovex International
INVX
$2.21B
| $2.22M | ﹤0.01% |
81,562
+11,356
| +16% | +$271K |
|
2714
CALL
CONMED
CNMD
$1.51B
| $2.22M | ﹤0.01% |
25,000
| – | – |
|
2715
Terex
TEX
$7.55B
| $2.21M | ﹤0.01% |
51,827
-46,785
| -47% | -$1.88M |
|
2716
Brink's
BCO
$4.86B
| $2.21M | ﹤0.01% |
41,203
-13,186
| -24% | -$764K |
|
|
IIVI
2717
DELISTED
Coherent Corp. 6.00% Series A Mandatory Convertible Preferred Stock
IIVI
| $2.21M | ﹤0.01% |
13,829
+10,000
| +261% | +$1.61M |
|
2718
Eversource Energy
ES
$27.3B
| $2.21M | ﹤0.01% |
26,359
-191,367
| -88% | -$15.2M |
|
2719
Banner Corp
BANR
$2.44B
| $2.21M | ﹤0.01% |
34,936
-695
| -2% | -$46.7K |
|
2720
Kura Oncology
KURA
$841M
| $2.21M | ﹤0.01% |
177,835
-101,624
| -36% | -$1.48M |
|
2721
CALL
Chubb
CB
$134B
| $2.21M | ﹤0.01% |
10,000
-45,700
| -82% | -$9.51M |
|
2722
CALL
Rapid7
RPD
$720M
| $2.21M | ﹤0.01% |
64,900
+21,900
| +51% | +$783K |
|
2723
Lakeland Financial Corp
LKFN
$1.58B
| $2.2M | ﹤0.01% |
30,189
+817
| +3% | +$62.6K |
|
2724
CMS Energy
CMS
$22.5B
| $2.2M | ﹤0.01% |
34,724
-117,912
| -77% | -$6.97M |
|
2725
PUT
Olin
OLN
$2.17B
| $2.19M | ﹤0.01% |
41,400
-43,600
| -51% | -$2.31M |
|
Similar funds
D.E. Shaw & Co's Q4 2022 Portfolio in Review
As of Q4 2022, D.E. Shaw & Co held 5,609 positions worth $90.5B, up 8.1% from $83.7B the previous quarter. Its ten largest holdings account for 8.3% of the portfolio.
D.E. Shaw & Co's Q4 2022 filing shows 476 new, 1,793 increased, 1,541 reduced and 783 closed positions. Its largest new stake was iShares JPMorgan USD Emerging Markets Bond ETF: 3,017,047 shares worth $255M. The largest sale was Berkshire Hathaway Class B, an estimated $382M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Healthcare and Financials.
- D.E. Shaw & Co's largest Q4 2022 buy was iShares JPMorgan USD Emerging Markets Bond ETF: 3,017,047 shares worth $255M.
- D.E. Shaw & Co added most to Tesla in Q4 2022, an estimated $826M increase.
- D.E. Shaw & Co's biggest Q4 2022 reduction was Berkshire Hathaway Class B, cutting an estimated $382M.
- D.E. Shaw & Co fully exited Twitter, Inc. in Q4 2022, selling an estimated $267M.
- D.E. Shaw & Co's ten largest holdings make up 8.3% of its $90.5B portfolio in Q4 2022.
- D.E. Shaw & Co opened 476 new positions and closed 783 in Q4 2022.
- D.E. Shaw & Co's portfolio value rose 8.1% quarter-over-quarter to $90.5B.
Based on D.E. Shaw & Co's 13F filing for Q4 2022, filed 14 Feb 2023.